Staphylococcus aureus and Staphylococcus epidermidis are organisms that frequently cause conjunctivitis or blepharoconjunctivitis. We describe a patient with methicillin-resistant S. aureus and S. epidermidis conjunctivitis who was treated successfully using an extemporaneously prepared topical ophthalmic solution of vancomycin hydrochloride 31 mg/mL. Studies describing the preparation, stability, and comfort of this solution, as well as reports pertaining to efficacy, are reviewed. Controlled clinical trials evaluating the safety and efficacy of vancomycin ophthalmic solution have not yet been performed.
Get full access to this article
View all access options for this article.
References
1.
BaumL.Therapy for ocular bacterial infection.Trans Ophthalmol Soc UK1986; 105: 6977.
2.
BlumRA, RodvoldKA. Recognition and importance of Staphylococcus epidermidis infections.Clin Pharm1987; 6: 46475.
The choice of antimicrobial drugs.Med Lett Drug Ther1988; 30: 3340.
8.
OsbornE, BaumJL, Ernstc, KochP,. The stability of ten antibiotics in artificial tear solutions.Am J Ophthalmol1976; 82: 77580.
9.
BaumJL. Initial therapy of suspected microbial corneal ulcers. I. Broad antibiotic therapy based on prevalence of organisms.Surv Ophthalmol1989; 24: 97105.
MoonenS, DrieverC.Stability study on vancomycin eye drops (abstract). Proceedings of the ASHP annual meeting.American Society of Hospital Pharmacists, June 1989; 46: P31R.
